Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valine SCHEMBL869350 | 0.76 | SLC7A5 (0.71) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6444775 | 0.76 | — | — | |
| Valine SCHEMBL1729111 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL3286146 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL29008223 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL10725920 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL2875734 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL30548418 | 0.68 | SLC7A5 (0.79) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL28052598 | 0.68 | SLC7A5 (0.88) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL4582565 | 0.68 | SLC7A5 (0.88) | SLC7A5SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5514821-A | SKIN DISORDERS; MEDIATORS OF CELL GROWTH AND DIFFERENTIATION | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1996-05-07 | — | — | US | disclosed |